Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Lymphatic absorption, metabolism, and excretion of a therapeutic peptide in dogs and rats.

Zou Y, Bateman TJ, Adreani C, Shen X, Cunningham PK, Wang B, Trinh T, Christine A, Hong X, Nunes CN, Johnson CV, Zhang AS, Staskiewicz SJ, Braun M, Kumar S, Reddy VB.

Drug Metab Dispos. 2013 Dec;41(12):2206-14. doi: 10.1124/dmd.113.051524. Epub 2013 Oct 2.

PMID:
24088325
2.

Cannabinoid-1 receptor inhibition prevents the reduction of 24-hour energy expenditure with weight loss.

Strack AM, Nicolich S, Faidley T, Achanfuo-Yeboah J, Cunningham PK, Hora D Jr, Thompson D, Hickey G, Johnson-Levonas AO, Fong TM, Heymsfield SB.

Metabolism. 2012 Apr;61(4):546-53. doi: 10.1016/j.metabol.2011.09.002. Epub 2011 Oct 14.

PMID:
22001334
3.

In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.

McCann ME, Rickes EL, Hora DF, Cunningham PK, Zhang D, Brideau C, Black WC, Hickey GJ.

Am J Vet Res. 2005 Jul;66(7):1278-84.

PMID:
16111170
4.

The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.

Huskey SE, Dean BJ, Doss GA, Wang Z, Hop CE, Anari R, Finke PE, Robichaud AJ, Zhang M, Wang B, Strauss JR, Cunningham PK, Feeney WP, Franklin RB, Baillie TA, Chiu SH.

Drug Metab Dispos. 2004 Feb;32(2):246-58.

PMID:
14744948
5.

A potent, orally bioavailable benzazepinone growth hormone secretagogue.

DeVita RJ, Bochis R, Frontier AJ, Kotliar A, Fisher MH, Schoen WR, Wyvratt MJ, Cheng K, Chan WW, Butler B, Jacks TM, Hickey GJ, Schleim KD, Leung K, Chen Z, Chiu SL, Feeney WP, Cunningham PK, Smith RG.

J Med Chem. 1998 May 7;41(10):1716-28.

PMID:
9572898

Supplemental Content

Loading ...
Support Center